BioRestorative Reports Compelling Preliminary Data for FDA-Fast-Tracked BRTX-100 – an Autologous Stem Cell Therapy to Treat Chronic Lumbar Disc Disease
OrthoSpineNews
JUNE 13, 2025
June 13, 2025 (GLOBE NEWSWIRE) — BioRestorative Therapies, Inc. This data was shared at the prestigious ISSCR 2025 Annual Meeting in Hong Kong by Francisco Silva, Vice President of Research and Development. We have also obtained U.S.
Let's personalize your content